Results
1 -
10 of
90
(Click
here to explore results)
- Perspectives on natural product epigenetic modulators in chemical biology and medicine. Fanny L. Cherblanc, Robert W. M. Davidson, Paolo Di Fruscia, Nitipol Srimongkolpithak, Matthew J. Fuchter
, Nat. Prod. Rep.
, 2013
, 30
, 605
- Cyclic peptide drugs approved in the last two decades (2001–2021). Huiya Zhang, Shiyu Chen
, RSC Chem. Biol.
, 2022
, 3
, 18
- Disulfide-bridged peptide macrobicycles from nature. Benjamin K. W. Chung, Andrei K. Yudin
, Org. Biomol. Chem.
, 2015
, 13
, 8768
- Bacterial natural products in the fight against mosquito-transmitted tropical diseases. Raúl G. Saraiva, George Dimopoulos
, Nat. Prod. Rep.
, 2020
, 37
, 338
- Natural product and natural product derived drugs in clinical trials. Mark S. Butler, Avril A. B. Robertson, Matthew A. Cooper
, Nat. Prod. Rep.
, 2014
, 31
, 1612
- Isoform-selective histone deacetylase
inhibitors. Anton V. Bieliauskas, Mary Kay H. Pflum
, Chem. Soc. Rev.
, 2008
, 37
, 1402
- Peptidomimetics via modifications of amino acids and peptide bonds. Ilker Avan, C. Dennis Hall, Alan R. Katritzky
, Chem. Soc. Rev.
, 2014
, 43
, 3575
- Origin and bioactivities of thiosulfinated FK228. Xiangyang Liu, Grant C. Currens, Liang Xue, Yi-Qiang Cheng
, Med. Chem. Commun.
, 2019
, 10
, 538
- Development of second generation epigenetic agents. Philip Jones
, Med. Chem. Commun.
, 2012
, 3
, 135
- Histone deacetylase inhibitors for the treatment of cancer stem cells. M. Dvorakova, T. Vanek
, Med. Chem. Commun.
, 2016
, 7
, 2217